This finding suggests that the mechanism of action of DNMT3A mutations in T-ALL may be different to AML, possibly due to the necessity of contributing genetic or epigenetic aberrations in T-ALL compared to AML [27]. Here, DNMT3A is linked to acute lymphoblastic leukemia.